Key Points
- CFO Vikram Verghese sold 7,579 Heartflow shares at an average price of $50.11, generating approximately $379,784. The transaction, conducted under a pre-arranged Rule 10b5-1 plan, reduced his direct holdings by 4.22% to 171,949 shares.
- Verghese has made several additional sales in September, including 16,766 shares on September 18 and 29,714 shares on September 11, indicating a broader pattern of planned insider selling.
- Heartflow shares opened at $50.75, near their 52-week high of $52.22. The company recently reported revenue growth of 47.7% year over year and better-than-expected quarterly EPS, while analysts maintain a “Moderate Buy” consensus rating with an average price target of $44.88.
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CFO Vikram Verghese sold 7,579 shares of the firm's stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of $50.11, for a total value of $379,783.69. Following the sale, the chief financial officer directly owned 171,949 shares in the company, valued at $8,616,364.39. This trade represents a 4.22% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Vikram Verghese also recently made the following trade(s):
- On Friday, September 18th, Vikram Verghese sold 16,766 shares of Heartflow stock. The shares were sold at an average price of $50.75, for a total value of $850,874.50.
- On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The shares were sold at an average price of $50.01, for a total transaction of $33,406.68.
- On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The stock was sold at an average price of $50.24, for a total transaction of $230,752.32.
- On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The stock was sold at an average price of $50.06, for a total transaction of $1,487,482.84.
- On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The shares were sold at an average price of $50.03, for a total transaction of $332,199.20.
- On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The shares were sold at an average price of $49.69, for a total transaction of $1,368,462.60.
- On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The stock was sold at an average price of $50.60, for a total transaction of $297,325.60.
Heartflow Price Performance
Shares of HTFL opened at $50.75 on Friday. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $52.22. The stock has a market cap of $4.41 billion and a PE ratio of -27.73. The firm has a fifty day moving average price of $37.75 and a 200 day moving average price of $31.70.
Heartflow (NASDAQ:HTFL - Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The company had revenue of $64.08 million for the quarter. The firm's revenue for the quarter was up 47.7% compared to the same quarter last year. As a group, equities analysts expect that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on the company. Morgan Stanley raised their price target on Heartflow from $35.00 to $40.00 and gave the stock an "equal weight" rating in a research note on Friday, August 14th. Benchmark reissued a "buy" rating on shares of Heartflow in a report on Friday, August 14th. Piper Sandler restated an "overweight" rating and set a $45.00 target price (up from $38.00) on shares of Heartflow in a research report on Friday, August 14th. Weiss Ratings raised shares of Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, August 7th. Finally, Canaccord Genuity Group upped their price target on shares of Heartflow from $37.00 to $45.00 and gave the company a "buy" rating in a research report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Heartflow currently has an average rating of "Moderate Buy" and an average price target of $44.88.
View Our Latest Stock Analysis on HTFL
Hedge Funds Weigh In On Heartflow
A number of hedge funds and other institutional investors have recently made changes to their positions in HTFL. Engineers Gate Manager LP acquired a new position in Heartflow in the 2nd quarter valued at about $590,000. Integrated Wealth Concepts LLC purchased a new stake in Heartflow during the 2nd quarter valued at approximately $53,000. Squarepoint Ops LLC lifted its position in Heartflow by 72.0% during the 2nd quarter. Squarepoint Ops LLC now owns 87,052 shares of the company's stock worth $2,554,000 after acquiring an additional 36,441 shares during the period. Arizona State Retirement System purchased a new position in shares of Heartflow in the 2nd quarter valued at approximately $312,000. Finally, Allianz Asset Management GmbH purchased a new position in shares of Heartflow in the 2nd quarter valued at approximately $1,557,000.
Heartflow Company Profile
(
Get Free Report)
Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient's coronary arteries.
The company's primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFRCT).
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
